Beretta Holding Proposes Partial Tender Offer for 20.05% of Ruger Shares, Demands Poison Pill Exemption

summarizeSummary

Activist investor Beretta Holding S.A. has formally proposed an all-cash partial tender offer to acquire an additional 20.05% of Sturm, Ruger & Co. shares at $44.80 per share, conditional on the Board granting an exemption from its "poison pill" rights plan.

check_boxKey Events

• Partial Tender Offer Proposed

  Beretta Holding S.A. proposes an all-cash partial tender offer to acquire an additional 20.05% of Sturm, Ruger & Co.'s outstanding shares, which would increase its total beneficial ownership to 30%.

• Offer Price at Premium

  The offer is for $44.80 per share, representing a significant premium of approximately 20% to the 60-day average price (VWAP).

• Demand for Poison Pill Exemption

  The tender offer is conditional on Ruger's Board granting an exemption from its "poison pill" rights plan by March 31, 2026.

• Escalation of Activist Campaign

  This proposal marks a significant escalation in the ongoing proxy fight and activist campaign by Beretta Holding, following previous proxy solicitations and a recent 13D/A filing on the same day.

auto_awesomeAnalysis

This filing escalates the ongoing proxy battle between activist investor Beretta Holding S.A. and Sturm, Ruger & Co. The proposed partial tender offer, valued at approximately $143 million and representing over 20% of Ruger's market capitalization, aims to increase Beretta's stake to 30%. The explicit demand for an exemption from the company's poison pill by March 31, 2026, puts significant pressure on Ruger's Board, forcing a critical decision that will determine the immediate future of the company's control and strategic direction. Investors should closely monitor the Board's response and the potential for further escalation or negotiation.